0001445305-12-001968.txt : 20120927 0001445305-12-001968.hdr.sgml : 20120927 20120608112132 ACCESSION NUMBER: 0001445305-12-001968 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120608 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MYLAN INC. CENTRAL INDEX KEY: 0000069499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 251211621 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 BUSINESS PHONE: 724-514-1800 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE CITY: CANONSBURG STATE: PA ZIP: 15317 FORMER COMPANY: FORMER CONFORMED NAME: MYLAN LABORATORIES INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: FRM CORP DATE OF NAME CHANGE: 19711003 CORRESP 1 filename1.htm June2012SECextensionletter
Mylan Inc.
1500 Corporate Drive
Canonsburg, PA 15317


June 8, 2012
VIA EDGAR
Mr. Jim B. Rosenberg         
Senior Assistant Chief Accountant
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.         
Washington, D.C. 20549-3628        

Re: Mylan Inc.
Form 10-K for Fiscal Year Ended December 31, 2011
Filed February 21, 2012
Form 10-Q for Quarterly Period Ended March 31, 2012
Filed April 27, 2012
File No. 001-9114

Mylan Inc. (the “Company”) confirms receipt of a comment letter from the Staff of the Division of Corporation Finance (the “Staff”) of the Securities and Exchange Commission dated May 30, 2012 relating to the above-referenced filings. Pursuant to our discussion with the Staff on June 6, 2012, the Company hereby confirms that it intends to provide its response to the Staff’s comments on or before June 22, 2012.

If you have any questions or comments with regard to this correspondence or any other matter, please do not hesitate to contact me at (724) 514-1800 (phone), (724) 514-1880 (fax) or john.sheehan@mylan.com.
Very truly yours,

/s/ John D. Sheehan
John D. Sheehan
Executive Vice President and
Chief Financial Officer